Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05934708 · ClinicalTrials.gov registry record · NA
Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
A NA study of Inflammatory Response, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05934708: Recruiting NA study of Inflammatory Response, sponsored by University of Southern California.
NCT05934708 is a NA study of Inflammatory Response that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 30 participants, below the 176-participant average among 16 other Inflammatory Response trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05934708, a NA study of Inflammatory Response, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The fluctuating concentrations of female sex hormones, namely estrogen and progesterone may have an effect on the ability of the tissue to withstand challenging exercise conditions, such as eccentric exercise. These sex hormones have also been purported to influence the perceived difficulty of exercise. This study aims to uncover how the different estrogen and progesterone concentrations present throughout the menstrual cycle effect perceived readiness to perform, perceptions of difficulty, and different recovery metrics.
Primary Outcome
Perceived readiness will be measured on an 11 point numeric rating scale (NRS) with 0 being not ready at all, and 10 being most prepared
Conditions Studied
Interventions
- BEHAVIORAL Eccentric leg extension
Study Locations (1)
California
- Clinical Exercise Research Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-07 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT05934708 shows while recruiting
NCT05934708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 176-participant average among 16 other Inflammatory Response trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Inflammatory Response appearing as the primary indexed condition, and to 1 intervention - of which Eccentric leg extension is the first listed.
NCT05934708 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05934708 about?
NCT05934708 is a clinical study titled "Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise". The fluctuating concentrations of female sex hormones, namely estrogen and progesterone may have an effect on the ability of the tissue to withstand challenging exercise conditions, such as eccentric exercise. These sex hormones have also been purported to influence the perceived difficulty of exerc...
What is the current status of trial NCT05934708?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-07. Estimated completion is 2026-08.
What conditions does trial NCT05934708 study?
This clinical trial studies the following conditions: Inflammatory Response.
What interventions are being tested in trial NCT05934708?
The interventions under investigation include: Eccentric leg extension (BEHAVIORAL).
Who is sponsoring clinical trial NCT05934708?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05934708 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Response
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05934708's enrollment target sits among peer trials
30 15th of 16 higher than 2 of 16 other Inflammatory Response trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Response trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
Association Between Body Composition and Pain in Spinal Cord Injury
RECRUITING · NA
-
Social Experiences and Demographic Factors in the Regulation of Immune Cells
RECRUITING · NA
-
Daoist Zhanzhuang and Human Flourishing
RECRUITING · NA
-
Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles
ACTIVE NOT RECRUITING · NA
-
Beef and Plant Burger Metabolomics Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI